Verified Nov 2026
Batteries & E-Mobility
·

Waltham, Massachusetts
·
Since 2003
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2003 and headquartered in Waltham, Massachusetts. With 500–1,000 employees and estimated revenue of $100–250 million, the company develops kinase inhibitor therapies targeting cancer. It holds FDA approval for QINLOCK (Ripretinib) for advanced gastrointestinal stromal tumors and maintains a pipeline in oncology. Since April 2024, Deciphera operates as a wholly owned subsidiary of Ono Pharmaceutical.
Deciphera Pharmaceuticals at a glance
Revenue
$100-250M
Est. band
Employees
500-1,000
Founded
2003
Headquarters
Waltham, Massachusetts
Industries
Automotive
Electric Vehicles
Medical
Industrial Equipment
Overview
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2003 and headquartered in Waltham, Massachusetts. With 500–1,000 employees and estimated revenue of $100–250 million, the company develops kinase inhibitor therapies targeting cancer. It holds FDA approval for QINLOCK (Ripretinib) for advanced gastrointestinal stromal tumors and maintains a pipeline in oncology. Since April 2024, Deciphera operates as a wholly owned subsidiary of Ono Pharmaceutical.
At a glance
Attribute | Detail |
|---|---|
Founded | 2003 |
Headquarters | Waltham, Massachusetts |
Employees | 500-1,000 |
Revenue | $100-250M (estimated) |
Primary capability | Batteries & E-Mobility |
What Deciphera Pharmaceuticals makes
Deciphera operates a proprietary switch-control kinase inhibitor platform designed to overcome resistance mechanisms and address multiple cancer-related mutations across its pipeline candidates.
Latest developments
2026-06-17 — Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera | Deciphera (deciphera.com)
2026-06-17 — News | Deciphera (deciphera.com)
2026-03-04 — Ono’s Deciphera drops early-stage solid tumor drug (fiercebiotech.com)
2026-02-17 — Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL | Deciphera (deciphera.com)
2025-11-17 — Deciphera Announces the Opening of a New Office in Zug, Switzerland (businesswire.com)
2025-09-17 — Deciphera Receives European Commission Approval of ROMVIMZA™ (vimseltinib) for the Treatment of Tenosynovial Giant Cell Tumor (TGCT) | Deciphera (deciphera.com)
Facilities
Deciphera Pharmaceuticals is headquartered in Waltham, Massachusetts. Public sources also reference these locations:
Lawrence, KS — deciphera.com
Waltham, Massachusetts — akta.pro
Company details
As a subsidiary of Ono Pharmaceutical, the company serves oncology markets globally and maintains facilities in Waltham, Massachusetts and Lawrence, Kansas. Deciphera Pharmaceuticals was founded in 2003, has an estimated 500-1,000 employees, and is headquartered in Waltham, Massachusetts.
Frequently asked questions
What does Deciphera Pharmaceuticals make?
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company founded in 2003 and headquartered in Waltham, Massachusetts. With 500–1,000 employees and estimated revenue of $100–250 million, the company develops kinase inhibitor therapies targeting cancer. It holds FDA approval for QINLOCK (Ripretinib) for advanced gastrointestinal stromal tumors and maintains a pipeline in oncology. Since April 2024, Deciphera operates as a wholly owned subsidiary of Ono Pharmaceutical.
Where is Deciphera Pharmaceuticals headquartered?
Deciphera Pharmaceuticals is headquartered in Waltham, Massachusetts (200 Smith St, Waltham, Massachusetts, 02451).
When was Deciphera Pharmaceuticals founded?
Deciphera Pharmaceuticals was founded in 2003.
How big is Deciphera Pharmaceuticals?
Deciphera Pharmaceuticals has an estimated 500-1,000 employees, with revenue in the $100-250M range (estimated).
Related suppliers
Explore other suppliers in the LightSource directory:
Last verified Nov 2026. Is this your company? Request a correction.
Location & contact
Evaluating suppliers like these?
This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.
